HCA Healthcare, Inc.
NYSE-HCA
Dec '05
Dec '09
Dec '13
Dec '17
Dec '21
LTM
| Income Statement | LTM | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 74,372 | 70,603 | 64,968 | 60,233 | 58,752 | 51,533 | 51,336 | 46,677 | 43,614 | 41,490 | 39,678 |
Total Revenues %Chg | 6.8% | 8.7% | 7.9% | 2.5% | 14% | 0.4% | 10% | 7% | 5.1% | 4.6% | 7.5% |
Cost of Sales | 43,599 | 41,925 | 39,389 | 37,056 | 36,260 | 32,243 | 32,041 | 29,149 | 27,375 | 25,830 | 24,753 |
Gross Profit | 30,773 | 28,678 | 25,579 | 23,177 | 22,492 | 19,290 | 19,295 | 17,528 | 16,239 | 15,660 | 14,925 |
Gross Profit Margin | 41.4% | 40.6% | 39.4% | 38.5% | 38.3% | 37.4% | 37.6% | 37.6% | 37.2% | 37.7% | 37.6% |
Depreciation & Amortization Expenses | 3,468 | 3,312 | 3,077 | 2,969 | 2,853 | 2,721 | 2,596 | 2,278 | 2,131 | 1,966 | 1,904 |
Other Operating Expenses | 15,672 | 14,819 | 12,875 | 11,155 | 9,961 | 9,307 | 9,481 | 8,608 | 8,051 | 7,492 | 7,305 |
Operating Profit | 11,633 | 10,547 | 9,627 | 9,053 | 9,678 | 7,262 | 7,218 | 6,642 | 6,057 | 6,202 | 5,716 |
Operating Margin | 15.6% | 14.9% | 14.8% | 15% | 16.5% | 14.1% | 14.1% | 14.2% | 13.9% | 14.9% | 14.4% |
Interest and Investment Income | 63 | 23 | 22 | 45 | 113 | 54 | 43 | 29 | 45 | 54 | 46 |
Interest Expense | -2,204 | -2,061 | -1,938 | -1,741 | -1,566 | -1,584 | -1,824 | -1,755 | -1,690 | -1,707 | -1,665 |
Non-Operating Income | — | 14 | -5 | 1,223 | 1,608 | -302 | -193 | 419 | -31 | 269 | -140 |
Total Non-Operating Income | -2,141 | -2,024 | -1,921 | -473 | 155 | -1,832 | -1,974 | -1,307 | -1,676 | -1,384 | -1,759 |
Income Before Provision for Income Taxes | 9,293 | 8,523 | 7,706 | 8,580 | 9,833 | 5,430 | 5,244 | 5,335 | 4,381 | 4,810 | 3,957 |
Provision for Income Taxes | 1,988 | 1,866 | 1,615 | 1,746 | 2,112 | 1,043 | 1,099 | 946 | 1,638 | 1,378 | 1,261 |
Consolidated Net Income | 7,305 | 6,657 | 6,091 | 6,834 | 7,721 | 4,387 | 4,145 | 4,389 | 2,743 | 3,432 | 2,696 |
Net Income Attributable to Minority Interests and Other | 961 | 897 | 849 | 1,191 | 765 | 633 | 640 | 602 | 527 | 542 | 567 |
Net Income Attributable to Common Shareholders | 6,344 | 5,760 | 5,242 | 5,643 | 6,956 | 3,754 | 3,505 | 3,787 | 2,216 | 2,890 | 2,129 |
Basic EPS | 26.1 | 22.3 | 19.3 | 19.4 | 21.5 | 11.1 | 10.3 | 10.9 | 6.1 | 7.5 | 5.1 |
Diluted EPS | 25.9 | 22 | 19 | 19.2 | 21.2 | 10.9 | 10.1 | 10.7 | 6 | 7.3 | 5 |
Basic Weighted Average Shares Outstanding | 246.3 | 258.6 | 272.4 | 290.3 | 323.3 | 338.3 | 341.2 | 347.3 | 362.3 | 383.6 | 414.2 |
Total Shares Outstanding | 229.8 | 250 | 265.5 | 277.4 | 305.5 | 339.4 | 338.4 | 342.9 | 350.1 | 370.5 | 398.7 |
Diluted Weighted Average Shares Outstanding | 245.7 | 261.8 | 276.4 | 294.7 | 328.8 | 343.6 | 348.2 | 355.3 | 372.2 | 395.9 | 426.7 |
EBITDA | 15,101 | 13,859 | 12,704 | 12,022 | 12,531 | 9,983 | 9,814 | 8,920 | 8,188 | 8,168 | 7,620 |
Effective Tax Rate | 21.4% | 21.9% | 21% | 20.3% | 21.5% | 19.2% | 21% | 17.7% | 37.4% | 28.6% | 31.9% |